Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?
about
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.Realistic expectations of prepulse inhibition in translational models for schizophrenia research.A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive ValidityMouse genetic models for prepulse inhibition: an early reviewTAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple ParadigmsInhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.Anatomical transcriptome of G protein-coupled receptors leads to the identification of a novel therapeutic candidate GPR52 for psychiatric disorders.Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gatingAntipsychotic-like effects of a neurotensin receptor type 1 agonist.The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission.Influence of aripiprazole, risperidone, and amisulpride on sensory and sensorimotor gating in healthy 'low and high gating' humans and relation to psychometryNovel Therapeutic GPCRs for Psychiatric Disorders.Optimal treatment of Alzheimer's disease psychosis: challenges and solutions.Further characterization of the predictive validity of the Brattleboro rat model for antipsychotic efficacyModulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in miceExploring the role of 5-HT1A receptors in the regulation of prepulse inhibition in mice: implications for cross-species comparisons.Protein Phosphatase 2a and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-Type potassium channel activityModeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery.Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.Activation of nociceptin/orphanin FQ peptide receptors disrupts visual but not auditory sensorimotor gating in BALB/cByJ mice: comparison to dopamine receptor agonists.Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in miceDevelopmental etiology for neuroanatomical and cognitive deficits in mice overexpressing Galphas, a G-protein subunit genetically linked to schizophrenia.Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69LSensorimotor gating in neurotensin-1 receptor null mice.Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.Behavioral and neurobiological changes in C57BL/6 mouse exposed to cuprizone: effects of antipsychotics.Impaired prepulse inhibition and prepulse-elicited reactivity but intact reflex circuit excitability in unmedicated schizophrenia patients: a comparison with healthy subjects and medicated schizophrenia patients.Short-term selective breeding for high and low prepulse inhibition of the acoustic startle response; pharmacological characterization and QTL mapping in the selected linesDeveloping translational animal models for symptoms of schizophrenia or bipolar maniaReliability, robustness, and reproducibility in mouse behavioral phenotyping: a cross-laboratory studyUsing the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Effect of adrenalectomy and corticosterone replacement on prepulse inhibition and locomotor activity in mice.Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction.Acoustic Startle Reflex and Prepulse Inhibition.Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigmEnhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia.Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice.Reversal of startle gating deficits in transgenic mice overexpressing corticotropin-releasing factor by antipsychotic drugs.Disruption of prepulse inhibition in mice lacking mGluR1.
P2860
Q24609188-10C74C45-75EC-4306-A691-D18EBEF4AEA2Q24645703-8907C286-6DC6-4216-B288-DB7EC029F62DQ27300760-388716D5-5E63-4D0C-BA3A-28C339DC2163Q28217163-CAC6E74B-8736-41BF-80A2-3956D0AC5CE5Q28384192-CB5C3CB3-0193-4650-B231-A9451C62DD87Q28385659-033CF09D-08A2-4F36-A35D-47ECD7395D34Q28506753-30ED8A1D-B6C9-4163-9944-8276F7751BC4Q28589225-E3EB6000-72AC-4C27-BF68-8BA615FABC43Q30356261-436F9E7F-2503-4D66-817E-B2B77F1681C4Q30384607-A88D6D3C-88CE-4AAC-AC88-61A1B25C9DA5Q30404054-6120F544-12FD-4BE5-A0B0-2FABA18F91C1Q30407406-891A0C0D-A205-4D05-8194-E26AFA7840EFQ30423717-1ABA67AE-2086-4316-B19C-F6144944E4ECQ30427588-9C45E77E-86FE-4F01-9991-EE5ED01226FFQ30444290-8690044C-C68A-46E0-BFB5-390E641291BFQ30444307-6ED38822-BEB7-46E7-ABAE-337911A1D03EQ30445781-28988207-3F3D-4FA9-9093-A7711D0750E6Q30454958-55639714-3E72-4C89-8CA3-5CDC5251352BQ30457634-804348BA-9199-4529-9CC7-E1DB7C10C2E1Q30459631-F40E6B02-1560-488A-BD49-CCC74B768FEFQ30468003-68D9D854-B2E8-4DA8-887F-A84AB9A8D53BQ30469285-94E1282B-319C-4A8F-AF92-81EB754D696FQ30469594-5B6E01A7-0322-4DF7-B42F-63E55241ED58Q30472097-8836C5FA-3908-4C79-9DD7-20C0E048B90BQ30477911-F6C54A8C-9F7B-4817-8EF2-99BE0CD1B568Q30480449-531CF19E-F716-4648-9B9D-DEBE9F70E132Q30482602-CB781CFD-56DF-4A4A-9F11-D1C1B36EF0A5Q30484437-DECD498B-CAC6-4650-97FD-9ABDDA69831DQ30486395-8C0D30F8-C6F6-48AD-9EF8-D79514E7187DQ30487857-98F49CD6-C246-48AC-B892-0C387E78222BQ30487860-A5D87019-3F10-4895-B116-AEC1BB02F69CQ30489404-18F8058A-337C-4EDC-B843-3AA8BDD9C7CBQ30498681-ECF5939A-40B7-4E5B-ADC1-9F09BB185B80Q30498942-34EB237A-8232-4CE5-A4F8-55A7A83DB933Q40841724-9D0C4004-B902-4242-895F-E39F8F721460Q40881700-DD5739DA-CCAC-45B7-87DB-158B96515AEFQ42974942-687A6CB0-0AD0-4943-98BC-08FFEB682F83Q44259233-0DFF0339-12D8-4AAE-B34F-7D731985C84FQ44515018-27071821-B9CD-4FD5-9853-752A0845093DQ44700267-FE63B07A-5A42-4F1D-8AC1-EF49BE4DD70D
P2860
Drug-induced potentiation of prepulse inhibition of acoustic startle reflex in mice: a model for detecting antipsychotic activity?
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@en
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@nl
type
label
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@en
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@nl
prefLabel
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@en
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@nl
P2093
P356
P1433
P1476
Drug-induced potentiation of p ...... ecting antipsychotic activity?
@en
P2093
P2888
P304
P356
10.1007/S002130100763
P577
2001-07-01T00:00:00Z
P6179
1011530248